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Abstract Simple and convenient synthesis of 8-bromoflavone was achieved, 
starting from 2-bromophenol through 3’-bromo-2’-hydroxyacetophenone 
whose preparation was managed to be solved by optimized Fries 
rearrangement. The Buchwald-Hartwig reaction of 8-bromoflavone with 
different type of primary and secondary amines was carried out. 
Key words palladium, Buchwald-Hartwig reaction, flavones, catalysis, Fries 
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Flavones (2-aryl-4H-1-benzopyran-4-ones) are widespread in 
nature mostly as plant metabolites.1 Beside their frequent 
occurrence, flavones also show versatile biological activities, e. 
g. antioxidant, anti-inflammatory, antimicrobial properties.2 
Noteworthy that many aminoflavone derivatives have 
considerable enzyme inhibitory effect as -glucosidase,3 
tyrosin-kinase,4 cyclin-dependent kinase5 inhibitors, in addition, 
antiproliferative,6 antitumor,7 cytotoxic effect8 and central 
nervous system protective properties9 were also observed. 
Most syntheses of flavones are based on the corresponding 
chromone (4H-1-benzopyran-4-one) core structure by 
conventional methods. However, synthesis of aminoflavones is 
suffering from limitations, especially in the case of derivatives 
linked their amine substituents to Ring A. The most common 
synthetic methods based on Baker-Venkataraman 
rearrangement10,11 or Claisen-Schmidt condensation12,13 
(Scheme 1). 
The main problems of these methods are the synthesis of the 
corresponding acetophenone 1 is limited by the regioselectivity 
of the acetophenone’s nitration and/or the sensitivity of the R1 
substituents under the harsh conditions of nitration. An 
alternative way is the nitration and reduction of previously 
prepared flavone moiety but these possibilities are also limited 
by the regioselectivity and reactivity patterns of the nitration 
step.4b,9,14 
 
Scheme 1 Synthesis of aminoflavone derivatives by conventional methods. 
Synthesizing derivatives with alkyl/arylamino or disubstituted 
amino function represents a much greater challenge than the 
formation of the amino group. Due to the lack of selectivity, 
direct alkylation leads to low yields.6a,c, 15 
In the last decades Buchwald-Hartwig amination of halo 
substituted aromatic/heteroaromatic systems became useful 
method for synthesizing alkyl- and arylamino substituted 
arenes.16 Nevertheless, in the field of aminoflavone derivatives 
only sporadic examples have been published. The synthesis of 
4’-aminoisoflavone started from its bromide,8 while 7-amino-5-
hydroxyflavone was prepared from the corresponding triflate.17 
Caddick18 et al. used Buchwald-Hartwig reaction for the 
amination of bromo- or triflyloxy substituted flavones under 
microwave activation but only hexylamine was used as nitrogen 
source. 
Previously our group published the results of the amination of 
6- and 7-bromoflavone with different type of primary, 
secondary amines and aniline derivatives.19 Although Caddick18 
et al. mention the Buchwald-Hartwig amination of 8-
bromoflavone (6) with hexylamine, no other example was 
presented. Moreover, the synthesis of the 8-bromoflavone 
substrate is published only in Caddick’s paper18 according to our 
knowledge.  
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First, their own initial investigations toward the synthesis of 
haloflavones have been conducted using protocols based upon 
the classical Baker-Venkataraman O-acylation approach.20 
However, reactions proved to be relatively low yielding and 
slow to perform. At the end the synthesis of 8-bromoflavone 
was performed by the application of a C-acylation methodology 
described by Cushman21 for the synthesis of hydroxylated 
flavones. The method required the utilization of LHMDS at low 
temperature and 3’-bromo-2’-hydroxyacetophenone (8) as a 
starting material; however the source of compound 8 is not 
given in their article. 
 
In this paper we represent the synthesis of 8-bromoflavone (6) 
starting from the commercially available 2-bromophenol (10) 
and its Buchwald-Hartwig reaction with some aliphatic and 
aromatic amine derivatives. 
 
Scheme 2 Retrosynthesis of 8-bromoflavone (6). 
According to our retrosynthetic analysis the synthesis of 8-
bromoflavone (6) requires 3’-bromo-2’-hydroxyacetophenone 
(8), as a starting precursor, which can be prepared by Fries 
rearrangement of ester 9 after the acylation of the commercially 
available 2-bromophenol (10) (Scheme 2). The Claisen-Schmidt 
condensation of 8 with benzaldehyde results the 2’-
hydroxychalcone 7 and its oxidative ring closure could provide 
8-bromoflavone (6). 
 
The esterification of 2-bromophenol (10) with acetyl chloride in 
the presence of triethyl amine provided 2-bromophenylacetate 
(9) in excellent yield (98%). After the first Fries rearrangement 
experiment of ester 9, which was carried out in the usual neat 
condition, revealed that optimization is required because the 
reaction resulted exclusively 3’-bromo-4’-hydroxyacetophenone 
(11) and only traces of the desired 3’-bromo-2’-
hydroxyacetophenone (8) (Scheme 3). 
 
Scheme 3 Fries rearrangement of ester 9. 
 
Table 1 Synthesis of acetophenone 8 – optimization. 
Solvent 
Lewis
acid 
T (°C) t 
Yield of 
8 (%)
a
 
11
c
 10
c
 
neat AlCl3 100 3 h trace + - 
nitrobenzene ZnCl2 100 3 h 0 - - 
nitrobenzene AlCl3 100 45 min 0 + - 
1,4-dioxane AlCl3 100 3 h 0 - - 
carbon disulfide AlCl3 46 5 h 0 - - 
1,2-dichloroethane AlCl3 84 48 h 23 + + 
1,2-dichloroethane AlCl3 84 96 h 29 + + 
chlorobenzene AlCl3 130 3 h 37
b + + 
1,2-dichlorobenzene AlCl3 140 3 h 62 + + 
a
 Yields refer to pure isolated products 
b great amount of p-acetyl-chlorobenzene was formed 
c identification with standards by TLC monitoring, not isolated products  
 
In case of nitrobenzene, 1,4-dioxane and carbon disulfide the 
formation of the desired compound 8 was not detected. The 
application of ZnCl2 in nitrobenzene did not show even the 
formation of the para substituted acetophenone 11. Using 
different halogenated solvents acetophenone 8 was isolated in 
moderate yield. The rearrangement in para position was 
successfully reduced providing acetophenone 8 by using 
aluminum trichloride in 1,2-dichlorobenzene at 140°C (Table 1). 
Under these conditions beside the by-product 11, the 2-
bromophenol (10) was also detected in the reaction mixture 
which could not be separated by using classical 
chromatographic solvents. The addition of triethyl amine (TEA), 
as a basic component, to the dichloromethane (dichloromethane 
: triethyl amine = 20:1) dramatically and solely reduced the 
retention factor of 2-bromophenol (10) (Rf: 0.65→0.15) 
therefore its separation from compound 8 became possible 
(Figure 1). 
 
Figure 1 Thin-layer chromatography plates of acetophenone 8, 11 and phenol 
10 in different eluents (a 1,2-dichlorobenzene) 
In the case of product 8 the retention factor was changed to the 
higher position, that is, this compound does not behave as a 
phenolic compound, which phenomenon can be explained by 
the decreased acidity of the hydroxyl group due to the 
intramolecular chelate effect of the carbonyl group in compound 
8. The successfully separated 3’-bromo-2’-hydroxy-
acetophenone (8) was transformed into bromochalcone 7 with 
benzaldehyde by Claisen-Schmidt condensation. Using catalytic 
amount of iodine in hot dimethyl sulphoxide22 the ring-closure 
of the chalcone derivative 7 provided the desired 8-
bromoflavone (6) in high yield (Scheme 4). 
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Scheme 4 Synthesis of 6. Reagents and conditions: (i) 10 (1.0 equiv.), AcCl (1.1 
equiv.), TEA (1.1 equiv.), rt, DCM, 1 h; (ii) 9 (1.0 equiv.), AlCl3 (1.5 equiv.), 1,2-
dichlorobenzene, 140°C, 3 h; (iii) 8 (1.0 equiv.), PhCHO (1.5 equiv.), KOH in 
60% aqueous solution, EtOH, rt, 24 h; (iv) 7 (1.0 equiv.), I2 (0.08 equiv), 
DMSO, 180°C, 15 min. 
The Buchwald-Hartwig reaction of 6 with amines 12a–f (1.2 
equiv.) results the aminated flavone derivatives 13a–f in 
moderate and good yields (Scheme 5, Table 2). The reactions 
were carried out using Pd2(dba)3 (5 mol%) as catalyst, BINAP 
(7.5 mol%) as phosphane and NaOtBu (1.4 equiv.) as base in dry 
toluene at 110°C. 
 
Scheme 5 Synthesis of 13a-f. Reagents and conditions: (i) 6 (1.0 equiv.), 
Pd2(dba)3 (5 mol%), BINAP (7.5 mol%), amine 12a-f (1.2 equiv.), NaOtBu (1.4 
equiv.), dry toluene, 110°C, 3 h. 
Table 2 Yields of 13a-f. 
12,13 R1 R2 Yields of 13 (%)a 
a Bu H 51 
b Bn H 66 
c 4-Cl-C6H4 H 59 
d 4-MeO-C6H4 H 65 
e -(CH2)2N(CH3)(CH2)2- 50 
f -(CH2)2O(CH2)2- 47 
aYields refer to pure isolated products 
 
Beside the desired product 13a–f 3’-bromo-2’-
hydroxydibenzoylmethane (and its tautomeric form) (15) was 
observed. The appearance of this by-product can be explained 
by a concurrent ring-opening of the heterocycle under the 
applied basic condition. As we earlier19 showed a nucleophilic 
species e.g. tert-butoxide anion attacks the electrophilic C-2 
atom of the flavone moiety and the intermediate enol ether 14 
hydrolyses during the work-up and the column chromatography 
on silica as shown by Scheme 6. After the isolation 15 its 
structure elucidation was achieved by NMR, IR and MS 
measurements. 
 
Scheme 6 Ring opening reaction of 6 
All products were characterized by spectroscopic methods 
(NMR, IR, MS). The GC-MS measurements showed high purity 
which was also proven by the sharp melting points. The yields 
indicated in the tables refer to pure isolated yields in all cases. 
In conclusion, we have demonstrated the synthesis of 8-
bromoflavone (6) from the commercially available 2-
bromophenol through 3’-bromo-2’-hydroxyacetophenone (8), 
as a starting precursor. The synthesis of 8 was optimized and its 
further transformation to 8-bromoflavone (6) requires simple 
and convenient reaction conditions. Because the starting 
materials are easily accessible and the reactions give good 
yields, this new synthetic approach has potential applications in 
the synthesis of various functionalized flavones, which are of 
considerable interest as potential biologically active compounds 
or pharmaceuticals. The Buchwald-Hartwig amination of the 
prepared 8-bromoflavone (6) was studied with different 
primary and secondary amines. Further studies of the 
Buchwald-Hartwig reaction with different amino acid 
derivatives are currently underway in our laboratory. 
The experimental section has no title; please leave this line here. 
Column chromatography was performed on silica gel (Merck 60, 70-230 
mesh), eluents are given at the products. Thin layer chromatography was 
performed on aluminum backed TLC plates of silica gel 60 F254 (Merck, 
0.2 mm) with the indicated eluent. The purity of the compounds was 
established by GC-MS (Agilent 7890, Agilent 5975 MS detector) with 
positive EI at 70eV. NMR spectra were recorded on a Bruker AM 360 
(360.13 MHz for 1H, 90.03 MHz for 13C) spectrometer. Chemical shifts () 
are given from internal CHCl3 signals ( = 7.26 ppm) for 1H NMR and ( = 
77.00 ppm) for 13C NMR. Coupling constants (J in Hz) are accurate to 
±0.2 Hz for 1H. Melting point data were determined by using Büchi B-540 
equipment. Elemental analyses (C, H) were conducted using the 
Elementar Vario MicroCube instrument. IR spectra were measured in 
KBr disc with Perkin-Elmer FT-IR 16PC or Jasco FT-IR 4100A equipment. 
 
Synthetic procedure of 3’-bromo-2’-hydroxyacetophenone (8): 
Commercially available 2-bromophenol (10) (10.0 g, 57.8 mmol) was 
dissolved in 50 mL dry dichloromethane in a round bottom flask, acetyl 
chloride (5.0 g, 63.6 mmol) and TEA (4.67mL, 63.6 mmol) were added 
and stirred at room temperature for 1 hour. The solvent was evaporated 
under reduced pressure to give the pure 2’-bromophenylacetate (9) 
(12.18 g, 56.6 mmol, yield: 98%). The 9 ester was dissolved in 100 mL 
1,2-dichlorobenzene, then aluminum chloride (11.3 g, 84.9 mmol) was 
added. The mixture was heated and stirred at 140°C for 3 hours. Ice and 
10% HCl was added till slightly acidic pH. The organic phase was 
separated in separation funnel, the water phase was extracted with 
dichloromethane then the combined organic phase was dried on 
magnesium sulfate, and filtered. The dichloromethane was evaporated 
under vacuum. The crude residue was treated with hexane (300 mL) and 
cooled at -20°C when most of the para substituted by-product 11 was 
crystallized and filtered off. The solution was filtered through silica and 
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washed with hexane till the 1,2-dichlorobenzene was eluted then the 
eluent was changed to DCM:TEA = 20:1. After chromatography and 
evaporation of the eluent the pure product 3’-bromo-2’-
hydroxyacetophenone (8) was isolated (7.55 g, 35.1 mmol, yield: 62%). 
 
 
3’-bromo-2’-hydroxyacetophenone (8) : 7.55 g, (62%), oil 
1H-NMR(CDCl3): δ: 12.97 (s, 1H, OH), 7.73 (m, 2H, 4-H, 6-H), 6.82 (t, J = 
7.9 Hz, 1H, 5-H), 2.66 (s, 3H, CH3) 13C-NMR(CDCl3): δ: 204.3 (C=O), 158.9 
(C-2), 139.6 (C-4),129.9 (C-6), 120.5 (C-1), 119.6 (C-5), 112.0 (C-3), 26.7 
(CH3) IR: (ATR) υ/cm-1: 3008, 2925, 2570, 1643, 1473, 1428, 1364, 
1250, 1146, 1071, 968, 836, 775, 738, 627, 595, 523, 437. MS: 214 [M+∙], 
216 [M+∙+2, 100%], 201, 199, 143, 145, 92, 77, 63 Anal. Calcd for 
C8H7BrO2: C, 44.68; H, 3.28, Found: C, 44.50; H, 3.19. 
 
Synthetic procedure of 3’-bromo-2’-hydroxychalcone (7): To the 
solution of 3’-bromo-2’-hydroxyacetophenone (8) (7.55 g, 35.1 mmol) 
and ethanol (40 mL), benzaldehyde (5.4 mL, 52.6 mmol) and 60% KOH 
in aqueous solution (45 mL, 0.8 mol, 22 equiv.) was added. The orange 
solution was stirred for 30 minutes then let it stand for overnight at 
ambient temperature. At a work-up procedure 10% HCl was added up to 
pH = 1, the precipitation was filtered and washed with water to give as 
yellow crystals of 7 (9.68 g, 31.9 mmol, yield: 91%). 
 
3’-bromo-2’-hydroxychalcone (7) : 9.68 g (91%), orange solid, Mp: 
116-119°C 
1H-NMR(CDCl3): δ: 13.61 (s, 1H, OH), 7.96 (d, J = 15.4 Hz, 1H, β-H), 7.90 
(dd, J = 8.0, 1.1 Hz, 1H, 5-H), 7.76 (dd, J = 7.8, 0.9 Hz, 1H, 7-H), 7.65 (m, 
3H, 2,6-H, α-H), 7.45 (m, 3H, 3,5-H, 4-H), 6.86 (t, J = 7.9 Hz, 1H, 6-H) 13C-
NMR(CDCl3): δ: 193.3 (C=O), 160.0 (C-2’), 146.6 (C-β),139.4 (C-4’), 134.3 
(C-1), 131.3 (C-4), 129.1 (C-3,5),128.8 (C-2,6, C-6’), 120.8 (C-1’), 119.5 
(C-α), 119.4 (C-5’), 112.3 (C-3’) IR: (ATR) υ/cm-1: 3443, 3063, 2858, 
2768, 1948, 1639, 1573, 1472, 1425, 1333, 1226, 1145, 1044, 978, 858, 
756, 700, 580. MS: 302 [M+∙], 304 [M+∙+2], 303 [M+H+∙, 100%], 305 
[M+H+∙+2], 287, 285, 227, 225, 200, 198, 165, 145, 143, 131, 119, 103,  
92, 77, 63, 51 Anal. Calcd for C15H11BrO2: C, 59.43; H, 3.66, Found: C, 
59.31; H, 3.56. 
 
Synthetic procedure of 8-bromoflavone (6): To the solution of 3’-
bromo-2’-hydroxychalcone (7) (9.68 g, 31.9 mmol) in dimethyl sulfoxide 
(60 mL) iodine (650 mg, 2.55 mmol) was added and mildly refluxed for 
15 minutes. The mixture was poured into 10 % sodium sulfite aqueous 
solution (300 mL), and stirred. The solid product 6 was filtered and 
washed with hexane:acetone = 5:1 eluent (8.46 g, 28.1 mmol, yield: 
88%).  
 
8-bromoflavone (6) : 8.46 g (88%), white solid, Mp: 181.0-182.0°C 
1H-NMR(CDCl3): δ: 8.14 (m, 3H, 5-H, 2’,6’-H), 8.01 (d, J = 7.9 Hz 1H, 7-H), 
7.62 (m, 3H, 3’,5’-H, 4’-H), 7.43 (t, J = 7.9 Hz, 1H, 6-H), 7.15 (s, 1H, 3-H) 
13C-NMR(CDCl3): δ: 176.6 (C-4), 162.4 (C-2), 152.0 (C-8a), 137.4 (C-7), 
132.1 (C-4’), 130.7 (C-1’), 129.2 (C-3’,5’), 126.4 (C-5), 126.3 (C-2’,6’), 
124.7 (C-4a), 124.5 (C-6), 111.5 (C-8), 106.9 (C-3) IR: (ATR) υ/cm-1: 
3444, 3070, 2309, 1959, 1646, 1472, 1370, 1236, 1103, 1068, 1021, 916, 
853, 771, 689, 627, 518, 503, 451, 418. MS: 300 [M+∙], 302 [M+∙+2, 100%], 
274, 272, 200, 198, 172, 170, 137, 135, 119, 102, 82, 63 Anal. Calcd for 
C15H9BrO2: C, 59.83; H, 3.01, Found: C, 59.78; H, 2.98. 
 
General procedure for 8-alkyl/arylamino-flavone derivatives (13a-
f): 
To a mixture of 8-bromoflavone (5) (200 mg, 0.66 mmol), NaOtBu (88 
mg, 0.92 mmol), BINAP (32 mg, 0.050 mmol) and amine (12a-f) (0.80 
mmol) in dry toluene (6 mL), Pd2(dba)3 (30 mg, 0.032 mmol) was added 
in a dried flask under nitrogen. The reaction mixture was stirred and 
refluxed at 110°C for 3 hours in oil bath. The crude reaction mixture was 
filtered on silica with pure acetone, to the filtrated small amount of silica 
was added then the solvent was removed under reduced pressure. The 
residue was purified by column chromatography to give the pure cross-
coupled product 13a-f as yellow solid. (The eluent ratio is given at each 
compound) 
 
Only representative examples are given here, the vast majority of the 
characterizations are presented in the Supporting Information. 
 
 
8-(butylamino)flavone (13a) : 99 mg (51%), Mp: 91.5-93.5 °C, Eluent : 
toluene:ethyl acetate = 8:1 
1H-NMR(CDCl3): δ: 7.83 (m, 2H, 2’,6’-H), 7.54 (m, 3H, 3’,5’-H, 4’-H), 7.48 
(d, J = 7.9 Hz 1H, 5-H), 7.25 (t, J = 7.9 Hz, 1H, 6-H), 6.89 (d, J = 7.9 Hz, 1H, 
7-H), 6.77 (s, 1H, 3-H), 4.45 (s, 1H, N-H), 3.28 (m, 2H, 1”-H), 1.74 (p, J = 
7.2 Hz, 2H, 2”-H), 1.51 (s, J = 7.2 Hz, 2H, 3”-H), 1.02 (t, J = 7.2 Hz. 2H, 4”-
H) 13C-NMR(CDCl3): δ: 178.8 (C-4), 162.4 (C-2), 144.8 (C-8a), 138.1 (C-
8), 132.3 (C-1’), 131.4 (C-4’), 129.2 (C-3’,5’), 126.2 (C-2’,6’), 125.6 (C-6), 
123.8 (C-4a), 112.9 (C-7), 111.7 (C-5), 108.0 (C-3), 43.5 (C-1”), 31.5 (C-
2”), 20.4 (C-3”), 13.9 (C-4”) IR: (ATR) υ/cm-1: 3444, 3061, 2961, 2931, 
2857, 1904, 1815, 1638, 1590, 1483, 1452, 1375, 1309, 1212, 1149, 
1043, 878, 771, 738, 687, 536, 501. MS: 293 [M+∙], 250 (100%), 148, 107, 
65 Anal. Calcd for C19H19NO2: C, 77.79; H, 6.53; N, 4.77, Found: C, 77.75; 
H, 6.50; N, 4.73. 
 
 
8-[(4-methoxyphenyl)amino]flavone (13d): 148 mg (65%), Mp: 
170.0-172.0 °C, Eluent : toluene:ethyl acetate = 8:1 
1H-NMR(CDCl3): δ: 7.85 (m, 2H, 2’,6’-H), 7.60 (dd, J = 7.4, 1.8 Hz 1H, 5-H), 
7.52 (m, 3H, 3’,5’-H, 4’-H), 7.21 (m, 4H, 6-H, 7-H, 2”,6”-H), 6.94 (d, 2H, J = 
8.8 Hz, 3”,5”-H), 6.79 (s, 1H, 3-H), 6.16 (s, 1H, N-H), 3.83 (s, 3H, OCH3) 
13C-NMR(CDCl3): δ: 178.6 (C-4), 162.6 (C-2), 156.7 (C-4”), 145.5 (C-8a), 
135.9 (C-1”), 133.8 (C-8), 132.1 (C-1’), 131.5 (C-4’), 129.1 (C-3’,5’), 126.3 
(C-2’,6’), 125.2 (C-6), 124.6 (C-2’,6’), 124.4 (C-4a), 116.1 (C-7), 115.0 (C-
3”,5”), 114.4 (C-5), 108.0 (C-3), 55.6 (OCH3) IR: (ATR) υ/cm-1: 3424, 
3298, 3004, 2951, 2830, 2320, 2062, 1633, 1582, 1509, 1379, 1244, 
1042, 896, 826, 770, 687, 546, 508, 453. MS: 343 [M+∙, 100%], 328, 226, 
170, 142, 120, 77 Anal. Calcd for C22H17NO3: C, 76.95; H, 4.99; N, 4.08, 
Found: C, 76.85; H, 4.94; N, 4.03. 
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8-Morpholinoflavone (13f): 96 mg (47%), Mp: 200.0-202.0 °C, Eluent : 
toluene:ethyl acetate = 4:1 
1H-NMR(DMSO): δ: 8.06 (m, 2H, 2’,6’-H), 7.65 (m, 4H, 5-H, 3’,5’-H, 4’-H), 
7.41 (m, 2H, 6-H, 7-H), 7.09 (s, 1H, 3-H), 3.90 (m, 2H, 3”,5”-H), 3.17 (m, 
2H, 2”,6”-H) 13C-NMR(DMSO): δ: 177.5 (C-4), 161.9 (C-2), 149.0 (C-8a), 
141.9 (C-8), 131.8 (C-4’), 131.4 (C-1’), 129.3 (C-3’,5’), 126.1 (C-2’,6’), 
125.4 (C-6), 124.3 (C-4a), 122.5 (C-7), 117.7 (C-5), 106.7 (C-3), 66.4 (C-
3”,5”), 51.4 (C-2”,6”) IR: (ATR) υ/cm-1: 3433, 3059, 2972, 2846, 2830, 
2753, 1638, 1576, 1485, 1447, 1376, 1240, 1113, 983, 855, 775, 749, 
689, 629, 532, 501, 458, 438. MS: 307 [M+∙, 100%], 276, 249, 231, 165, 
147, 119, 92 Anal. Calcd for C19H17NO3: C, 74.25; H, 5.58; N, 4.56, Found: 
C, 74.18; H, 5.50; N, 4.50. 
 
(3-bromo-2-hydroxyphenyl)-3-hydroxy-3-phenylprop-2-en-1-one 
(15) : Mp 136.0-138.5°C, Eluent : toluene:ethyl acetate = 8:1 This 
compound was obtained as a by-product from the reaction of amines and 
8-bromoflavone. 
1H-NMR (CDCl3): δ: 15.34 (s, 1H, β-OH), 12.87 (1H, s, 2’-OH), 7.94 (2H, d, 
2,6-H, J = 7.6 Hz), 7.74 (m, 3H, 3,5-H, 4-H), 7.50 (m, 2H, 4’-H, 6’-H), 6.83 
(m, 2H, 5’-H, α-H) 13C-NMR (CDCl3): δ: 194.8 (C=O), 180.0 (C-β), 158.9 
(C-2’), 138.9 (C-4’), 133.3 (C-1), 132.7 (C-4), 128.8 (C-3,5), 127.7 (C-6’), 
126.9 (C-2,6), 120.0 (C-1’), 119.7 (C-5’), 112.5 (C-3’), 92.3 (C-α) IR: 
(ATR) υ/cm-1: 3442, 3057, 2923, 2852, 1609, 1576, 1479, 1320, 1240, 
1178, 1099, 1057, 884, 756, 706, 681, 623. MS: 318 [M+∙], 320 [M+∙+2], 
121, 199, 105 (100%), 77, 51 Anal. Calcd for C15H11BrO3: C, 56.45; H, 
3.47, Found: C, 56.38; H, 3.40. 
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